Skip to main content

Nasdaq News

3 Dividend Aristocrats to Buy and Hold Forever

6 years 4 months ago
Dividend Aristocrats are S&P 500 companies that have raised their dividend payouts for at least 25 straight years. This remarkable run puts these large-cap stocks in rarefied company. After all, it's quite remarkable that they have provided dividend hikes for that many years

It's Time to Double Down on Starbucks Stock

6 years 4 months ago
If you own shares of Starbucks (NASDAQ: SBUX) right now or are on the verge of buying them, congratulations. You're obviously a forward-looking investor capable of blocking out the present headwinds.

Delta Might Not Be Done With Fleet Restructuring

6 years 4 months ago
The COVID-19 pandemic caused air travel demand to crash, upending the airline industry. One major result is that airlines have had to completely rethink their fleet strategies. Most airline executives expect demand to remain depressed for several years, which means that fewer ai

Will Nike Shock Investors Again This Week?

6 years 4 months ago
Nike (NYSE: NKE) surprised investors in late March by revealing strong operating trends in China despite challenging financial headwinds brought on by store closures from the COVID-19 pandemic. The footwear and apparel giant maintained its connection with shoppers during Februar

3 Dividend Stocks I'd Buy Right Now

6 years 4 months ago
Finding a good dividend stock can be challenging since there's so much uncertainty relating to the COVID-19 pandemic. However, investors simply need to adapt and look for safer options right now to minimize their exposure to the markets.

Does Gilead Have a Cure for the Coronavirus?

6 years 4 months ago
Gilead Sciences (NASDAQ: GILD) is among many biotech and pharmaceutical companies working on treatments for COVID-19, the illness caused by the novel coronavirus. Where Gilead stands apart is it actually has a treatment that the U.S. Food and Drug Administration (FDA) has author

What's the Outlook for Gilead Sciences?

6 years 4 months ago
For the last three years, Gilead Sciences (NASDAQ: GILD) hasn't done much more than treading water. Sure, the stock is up during the period, but all of the gains came in 2020 with COVID-19 drug remdesivir capturing investors' attention.

Everything You Need To Know About Teladoc

6 years 4 months ago
Teladoc Health (NYSE: TDOC) is the leader of telemedicine in the U.S. With its massive network of board-certified clinicians, Teladoc aims to supply health insurance companies and large employers with easy and remote access to doctors. 
Checked
15 minutes 11 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed